Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Dry January doesn't have to mean sober January — at least for the 21 percent of participants turning to cannabis or CBD to make it through the month.
SpaceX launched its Falcon 9 rocket to bring a powerful GPS satellite into orbit for the U.S. Space Force.
Moderna is applying for regulatory approval for its RSV vaccine, which it says has shown to be effective against the respiratory virus.
UN Secretary-General António Guterres on Wednesday called out ExxonMobil for withholding highly accurate predictions about the impact of climate change.
A new study has found that most Americans think it is okay to put tap water in medical devices such as humidifiers and neti pots, but experts say this is unsafe.
Cheddar News breaks down how China's population declined for the first time in 10 years.
Walgreens is no longer limiting the online sales of children's fever medicines after respiratory infections earlier send demand soaring.
Thousands in Spain lined up outside of their churches to have their pets blessed.
India is expected to become the world's most populous nation, according to the UN.
UFO sightings have jumped in the past two years, and half of them remain unexplained.
